GTG 0.00% 3.9¢ genetic technologies limited

The vast majority of the world(90%) remains at risk.., page-20

  1. 393 Posts.
    lightbulb Created with Sketch. 67

    Always easiest to say nothing when there's nothing to say. Investor presentation dated 16/09/20 "GeneType Breast Cancer and Colorectal tests are in market with anticipatedrelease of Cardiovascular and T2D tests in Q3 CY20" Clearly cardiovascular and Type 2 diabetes tests are another missed timeline.

 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.